ACTIVE

NOVIL'PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

130,2 k €

+48.2% YoY

Gross margin

304,1 k €

+2.2% YoY

Equity

744,4 k €

+5.9% YoY

Workforce

0,8 ETP

0.0% YoY

What does NOVIL'PHARMA do?

NOVIL'PHARMA is a Private limited company incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Fernelmont. It employs on average 0,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0870.124.840

Incorporation

23/11/2004

Legal form

Private limited company

Registered office

Rue de la Victoire, Nov. 6
5380 Fernelmont · WallonieSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Average workforce

0,8 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	304,1 k €	+2.2%	297,6 k €	+2.4%	290,6 k €	+9.5%	265,4 k €	+10.2%	240,8 k €	+5.2%	228,8 k €	+8.2%	211,5 k €	+565%	31,8 k €	-53.6%	68,5 k €	+5.4%	65 k €	-15.4%	76,9 k €	+77.7%	43,3 k €	-2.5%	44,4 k €	-13.1%	51 k €	-13.5%	59 k €	+4.1%	56,7 k €	-1.4%	57,5 k €	+19.4%	48,1 k €	-9.0%	52,9 k €	-8.2%	57,6 k €
EBITDA	260,2 k €	+1.7%	256 k €	+2.3%	250,1 k €	+9.2%	229,1 k €	+11.8%	204,9 k €	+5.9%	193,4 k €	+9.5%	176,6 k €	+458%	31,6 k €	-53.8%	68,5 k €	+5.6%	64,9 k €	-15.6%	76,9 k €	+77.7%	43,3 k €	-2.5%	44,4 k €	-13.1%	51 k €	-12.2%	58,1 k €	+8.9%	53,4 k €	-4.5%	55,9 k €	+16.1%	48,1 k €	-9.0%	52,9 k €	-8.2%	57,6 k €
Operating result	247,4 k €	+61.7%	153 k €	-20.8%	193,1 k €	+8.5%	177,9 k €	+16.1%	153,3 k €	+6.0%	144,6 k €	+19.6%	120,8 k €	+583%	17,7 k €	-67.6%	54,6 k €	+1.4%	53,8 k €	-18.2%	65,8 k €	+91.7%	34,3 k €	-3.1%	35,4 k €	-18.4%	43,4 k €	-14.0%	50,5 k €	+4.2%	48,4 k €	-5.0%	51 k €	+18.0%	43,2 k €	-11.5%	48,8 k €	-8.8%	53,5 k €
Net result	130,2 k €	+48.2%	87,8 k €	-29.9%	125,3 k €	+16.4%	107,7 k €	+10.3%	97,6 k €	-7.5%	105,6 k €	+32.2%	79,9 k €	+6779%	1,2 k €	-96.1%	29,8 k €	+8.5%	27,5 k €	-21.2%	34,8 k €	-87.7%	283,4 k €	+2223%	12,2 k €	-26.9%	16,7 k €	-16.2%	19,9 k €	+37.8%	14,5 k €	-6.5%	15,5 k €	+35.6%	11,4 k €	+2.5%	11,1 k €	-35.1%	17,1 k €
Balance sheet
Equity	744,4 k €	+5.9%	702,7 k €	+7.5%	653,9 k €	+11.1%	588,5 k €	+13.5%	518,4 k €	+16.3%	445,8 k €	-27.9%	618,2 k €	+67.2%	369,7 k €	+0.3%	368,6 k €	-12.2%	419,7 k €	+7.0%	392,3 k €	-0.3%	393,4 k €	+220%	123 k €	+0.6%	122,2 k €	+9.2%	111,9 k €	+13.7%	98,4 k €	+13.9%	86,4 k €	+17.8%	73,3 k €	+14.0%	64,3 k €	+15.7%	55,6 k €
Total assets	908 k €	-7.6%	982,3 k €	+3.0%	953,4 k €	+5.4%	904,8 k €	+9.9%	823,3 k €	-11.4%	928,9 k €	+6.3%	874 k €	-21.5%	1,1 M €	+3.9%	1,1 M €	+5.3%	1 M €	-1.7%	1 M €	+5.5%	980,5 k €	-0.9%	988,9 k €	+2.8%	962,2 k €	-1.6%	977,6 k €	+6.2%	920,1 k €	-3.6%	954,4 k €	+3.1%	925,9 k €	-0.1%	927 k €	+0.3%	924,5 k €
Cash	263,8 k €	-10.0%	293,1 k €	+205%	96,3 k €	-59.0%	234,8 k €	+29.8%	180,8 k €	+3.9%	174,1 k €	+41.9%	122,6 k €	+686%	15,6 k €	+89.1%	8,2 k €	-65.0%	23,6 k €	-13.2%	27,1 k €	+4154%	637,8 €	-65.9%	1,9 k €		–		6,3 k €	-47.0%	11,8 k €	-66.9%	35,8 k €	+487%	6,1 k €	-37.1%	9,7 k €	+3640%	259,1 €
Debts	163,6 k €	-30.0%	233,7 k €	-22.0%	299,5 k €	-4.8%	314,6 k €	+3.2%	304,9 k €	-36.9%	483,1 k €	+88.9%	255,8 k €	-65.6%	743,7 k €	+5.8%	702,8 k €	+17.7%	597,2 k €	-7.0%	642,1 k €	+9.4%	587 k €	-32.2%	866 k €	+3.1%	840 k €	-3.0%	865,6 k €	+5.3%	821,7 k €	-5.3%	868 k €	+1.8%	852,6 k €	-0.6%	857,5 k €	-1.3%	868,9 k €
Other
Workforce	0,8 ETP	0.0%	0,8 ETP		–		0,8 ETP	0.0%	0,8 ETP		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Poncelet Caroline

Director

Active

Verborg Sabine

Director

Active

Ended mandates

CAROLINE PONCELET

Manager · since 16 novembre 2004

Ended

SABINE VERBORG

Manager · since 16 novembre 2004

Ended

CAROLINE PONCELET

Manager

Ended

SABINE VERBORG

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Micro model	Abridged model	Abridged model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/08/2026	06/08/2025	30/08/2024	04/01/2024	31/08/2022	05/07/2021
General meeting	20/05/2026	21/05/2025	15/05/2024	17/05/2023	18/05/2022	19/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	20/05/2026	26/08/2026	French	PDF
Abridged model	31/12/2024	21/05/2025	06/08/2025	French	PDF
Micro model	31/12/2023	15/05/2024	30/08/2024	French	PDF
Abridged model	31/12/2022	17/05/2023	04/01/2024	French	PDF
Abridged model	31/12/2021	18/05/2022	31/08/2022	French	PDF
Micro model	31/12/2020	19/05/2021	05/07/2021	French	PDF
Micro model	31/12/2019	20/05/2020	21/08/2020	French	PDF
Abridged model	31/12/2018	15/05/2019	25/07/2019	French	PDF
Micro model	31/12/2017	16/05/2018	27/08/2018	French	PDF
Abridged model	31/12/2016	17/05/2017	27/07/2017	French	PDF
Abridged model	31/12/2015	18/05/2016	28/07/2016	French	PDF
Abridged model	31/12/2014	20/05/2015	06/08/2015	French	PDF
Abridged model	31/12/2013	21/05/2014	19/08/2014	French	PDF
Abridged model	31/12/2012	15/05/2013	21/08/2013	French	PDF
Abridged model	31/12/2011	16/05/2012	28/09/2012	French	PDF
Abridged model	31/12/2010	18/05/2011	24/08/2011	French	PDF
Abridged model	31/12/2009	19/05/2010	09/08/2010	French	PDF
Abridged model	31/12/2008	20/05/2009	20/08/2009	French	PDF
Abridged model	31/12/2007	05/05/2008	28/08/2008	French	PDF
Abridged model	31/12/2006	16/05/2007	10/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

Poncelet Caroline

Director

Active

Verborg Sabine

Director

Active

Ended mandates

CAROLINE PONCELET

Manager · since 16 novembre 2004

Ended

SABINE VERBORG

Manager · since 16 novembre 2004

Ended

CAROLINE PONCELET

Manager

Ended

SABINE VERBORG

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates07/07/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Restructuring01/03/2019
DENOMINATION - SIEGE SOCIAL - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring12/11/2018
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Capital / shares05/02/2018
CAPITAL, ACTIONS
PDF
Mandates12/05/2017
DEMISSIONS, NOMINATIONS
PDF
Capital / shares20/01/2014
CAPITAL, ACTIONS
PDF
Mandates05/12/2013
DEMISSIONS, NOMINATIONS
PDF
Mandates21/12/2007
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025130,2 k €↑
2024
Annual accounts 202487,8 k €↓
2023
Annual accounts 2023125,3 k €↑
2022
Annual accounts 2022107,7 k €↑
2021
Annual accounts 202197,6 k €↓
2020
Annual accounts 2020105,6 k €↑
2019
Annual accounts 201979,9 k €↑
2018
Annual accounts 20181,2 k €↓
2017
Annual accounts 201729,8 k €↑
2016
Annual accounts 201627,5 k €↓
2015
Annual accounts 201534,8 k €↓
2014
Annual accounts 2014283,4 k €↑
2013
Annual accounts 201312,2 k €↓
2012
Annual accounts 201216,7 k €↓
2011
Annual accounts 201119,9 k €↑
2010
Annual accounts 201014,5 k €↓
2009
Annual accounts 200915,5 k €↑
2008
Annual accounts 200811,4 k €↑
2007
Annual accounts 200711,1 k €↓
2006
Annual accounts 200617,1 k €
23/11/2004
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

NOVIL'PHARMA

Overview

What does NOVIL'PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline